MedPath

long-term effectiveness of eszopiclone on chronic insomina disorder in middle-aged wome

Not Applicable
Conditions
menopausal symptoms/chronic insomnia disorder
Registration Number
JPRN-UMIN000023690
Lead Sponsor
Tokyo Medical and Dental University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

women who are already treated with estrogens, antidepressants, anxiolytics, hypnotics etc. that are supposed to have effects on insomnia symptoms in middle-aged women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in objective sleep parameters measured by actigraphy after 12 and 24 weeks of treatment
Secondary Outcome Measures
NameTimeMethod
changes in Pittsburgh Sleep Quality Index, Athens Insomnia Scale, Epworth Sleepiness Scale, St. Marys Hospital Sleep Questionnaire, Menopause Health Related Quality of Life Questionnaire, and Hospital Anxiety and Depression Scale after 12 and 24 weeks of treatment
© Copyright 2025. All Rights Reserved by MedPath